{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:36:22Z","timestamp":1788543382368,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Impaired airway epithelial barrier function is a pathogenic driver in a subset of individuals with asthma. MicroRNAs, small RNAs that function as post-transcriptional regulators of gene expression, may be involved in the regulation of the airway epithelial barrier. This study aimed to determine if microRNAs cause epithelial barrier dysfunction through the targeting of mRNAs involved in maintaining airway epithelial barrier integrity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Primary human bronchial epithelial cells cultured at air\u2013liquid interface were stimulated with cytokines reflecting different asthma endotypes. Barrier integrity was assessed by FITC-labelled dextran flux. Differentially expressed epithelial barrier-related genes and microRNAs were identified by next-generation RNA sequencing and qPCR. Results were validated with microRNA pull-down, treatment with microRNA mimics and antagomirs, respectively, and evaluated in airway samples from subjects with asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A combination of IL-17A and TNF\u03b1, mimicking Th17 inflammation, was identified as a strong driver of epithelial barrier disruption, as compared to IL-4\u2009+\u2009IL-13, IL-6\u2009+\u2009sIL-6R, and TGF\u03b2. Several microRNAs induced by IL-17A and TNF\u03b1 stimulation were predicted to target barrier-related genes, which exhibited decreased expression in the same model. Of these microRNAs, miR-146a-3p and miR-363-3p were consistently induced in multiple donors. MicroRNA pull-down, overexpression, and knockdown experiments indicated a potential role for miR-363-3p interacting with several barrier-related genes, including\n                      <jats:italic>CLDN8<\/jats:italic>\n                      ,\n                      <jats:italic>PCDH1<\/jats:italic>\n                      , and\n                      <jats:italic>PTEN<\/jats:italic>\n                      . Bronchial lavage samples demonstrated an increase of miR-363-3p in individuals with asthma compared to healthy controls, as well as a positive correlation between miR-363-3p and the number of airway eosinophils and neutrophils.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our results support the role of microRNAs as mediators of cytokine-induced airway epithelial barrier dysfunction. Specifically, miR-363-3p appears to contribute to epithelial damage by targeting and suppressing gene expressions of several key barrier components, including\n                      <jats:italic>CLDN8<\/jats:italic>\n                      ,\n                      <jats:italic>PCDH1<\/jats:italic>\n                      , and\n                      <jats:italic>PTEN<\/jats:italic>\n                      , suggesting a novel role for this microRNA in Th17-driven airway disease. A better understanding of microRNA networks and their role in asthma pathogenesis may lead to novel biomarkers and therapeutic targets, which are currently needed for individuals with T2-low asthma and in Th17-driven asthma.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-025-03492-3","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:24:12Z","timestamp":1768530252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction"],"prefix":"10.1186","volume":"27","author":[{"given":"Cecilia","family":"L\u00e4sser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Winslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Ingelhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Calv\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Malmh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zala","family":"Jevnikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henric","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"R\u00e5dinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"3492_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1183\/13993003.01359-2015","volume":"47","author":"A Agusti","year":"2016","unstructured":"Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47:410\u20139.","journal-title":"Eur Respir J"},{"key":"3492_CR2","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1111\/all.13496","volume":"73","author":"ACA Yii","year":"2018","unstructured":"Yii ACA, Tay TR, Choo XN, Koh MSY, Tee AKH, Wang DY. Precision medicine in united airways disease: A \u201ctreatable traits\u201d approach. Allergy. 2018;73:1964\u201378.","journal-title":"Allergy"},{"key":"3492_CR3","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/all.13771","volume":"74","author":"KF Chung","year":"2019","unstructured":"Chung KF, Adcock IM. Precision medicine for the discovery of treatable mechanisms in severe asthma. Allergy. 2019;74:1649\u201359.","journal-title":"Allergy"},{"key":"3492_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","volume":"15","author":"JV Fahy","year":"2015","unstructured":"Fahy JV. Type 2 inflammation in asthma\u2013present in most, absent in many. Nat Rev Immunol. 2015;15:57\u201365.","journal-title":"Nat Rev Immunol"},{"key":"3492_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(08)61452-X","volume":"372","author":"GP Anderson","year":"2008","unstructured":"Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372:1107\u201319.","journal-title":"Lancet"},{"key":"3492_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54\u201361.","journal-title":"Respirology"},{"key":"3492_CR7","doi-asserted-by":"crossref","unstructured":"Ostling J, van Geest M, Schofield JPR, Jevnikar Z, Wilson S, Ward J, et al. IL-17-high asthma with features of a psoriasis immunophenotype. J Allergy Clin Immunol. 2019;144(5):1198-213.","DOI":"10.1016\/j.jaci.2019.03.027"},{"key":"3492_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","volume":"56","author":"ME Kuruvilla","year":"2019","unstructured":"Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56:219\u201333.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3492_CR9","doi-asserted-by":"crossref","unstructured":"Jevnikar Z, Ostling J, Ax E, Calven J, Thorn K, Israelsson E, Oberg L, Singhania A, Lau LCK, Wilson SJ, et al. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation. J Allergy Clin Immunol. 2019;143(2):577-90.","DOI":"10.1016\/j.jaci.2018.05.026"},{"key":"3492_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4193\/Rhino15.376","volume":"54","author":"B Steelant","year":"2016","unstructured":"Steelant B, Seys SF, Boeckxstaens G, Akdis CA, Ceuppens JL, Hellings PW. Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease. Rhinology. 2016;54:195\u2013205.","journal-title":"Rhinology"},{"key":"3492_CR11","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jaci.2020.04.010","volume":"145","author":"PW Hellings","year":"2020","unstructured":"Hellings PW, Steelant B. Epithelial barriers in allergy and asthma. J Allergy Clin Immunol. 2020;145:1499\u2013509.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR12","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.jaci.2017.04.005","volume":"139","author":"M Loxham","year":"2017","unstructured":"Loxham M, Davies DE. Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients. J Allergy Clin Immunol. 2017;139:1736\u201351.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR13","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/all.14421","volume":"75","author":"IH Heijink","year":"2020","unstructured":"Heijink IH, Kuchibhotla VNS, Roffel MP, Maes T, Knight DA, Sayers I, et al. Epithelial cell dysfunction, a major driver of asthma development. Allergy. 2020;75:1902\u201317.","journal-title":"Allergy"},{"key":"3492_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1139\/Y08-004","volume":"86","author":"WI de Boer","year":"2008","unstructured":"de Boer WI, Sharma HS, Baelemans SM, Hoogsteden HC, Lambrecht BN, Braunstahl GJ. Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can J Physiol Pharmacol. 2008;86:105\u201312.","journal-title":"Can J Physiol Pharmacol"},{"key":"3492_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP. Metazoan microRNAs. Cell. 2018;173:20\u201351.","journal-title":"Cell"},{"key":"3492_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.201201-0027OC","volume":"186","author":"OD Solberg","year":"2012","unstructured":"Solberg OD, Ostrin EJ, Love MI, Peng JC, Bhakta NR, Hou L, et al. Airway epithelial miRNA expression is altered in asthma. Am J Respir Crit Care Med. 2012;186:965\u201374.","journal-title":"Am J Respir Crit Care Med"},{"key":"3492_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1165\/rcmb.2011-0160OC","volume":"47","author":"MJ Jardim","year":"2012","unstructured":"Jardim MJ, Dailey L, Silbajoris R, Diaz-Sanchez D. Distinct microrna expression in human airway cells of asthmatic donors identifies a novel asthma-associated gene. Am J Respir Cell Mol Biol. 2012;47:536\u201342.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3492_CR18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.jaci.2016.02.018","volume":"137","author":"T Maes","year":"2016","unstructured":"Maes T, Cobos FA, Schleich F, Sorbello V, Henket M, De Preter K, et al. Asthma inflammatory phenotypes show differential microRNA expression in sputum. J Allergy Clin Immunol. 2016;137:1433\u201346.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR19","doi-asserted-by":"crossref","unstructured":"Weidner J, Bartel S, Kilic A, Zissler UM, Renz H, Schwarze J, Schmidt-Weber CB, Maes T, Rebane A, Krauss-Etschmann S, Radinger M. Spotlight on microRNAs in allergy and asthma. Allergy. 2021;76(6):1661-78.","DOI":"10.1111\/all.14646"},{"key":"3492_CR20","doi-asserted-by":"publisher","first-page":"e0266310","DOI":"10.1371\/journal.pone.0266310","volume":"17","author":"J Horndahl","year":"2022","unstructured":"Horndahl J, Sv\u00e4rd R, Berntsson P, Wingren C, Li J, Abdillahi SM, et al. HDAC6 inhibitor ACY-1083 shows lung epithelial protective features in COPD. PLoS ONE. 2022;17:e0266310.","journal-title":"PLoS ONE"},{"key":"3492_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12931-020-01402-3","volume":"21","author":"E Ax","year":"2020","unstructured":"Ax E, Jevnikar Z, Cvjetkovic A, Malmhall C, Olsson H, Radinger M, et al. T2 and T17 cytokines alter the cargo and function of airway epithelium-derived extracellular vesicles. Respir Res. 2020;21:155.","journal-title":"Respir Res"},{"key":"3492_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3492_CR23","doi-asserted-by":"crossref","unstructured":"Weidner J, Malmhall C, Arabkari V, Barrett A, Boberg E, Ekerljung L, et al. The serum\/glucocorticoid-regulated kinase 1 is targeted by miR-19a in CD4+ T cells. Cells. 2022;12(1):133.","DOI":"10.3390\/cells12010133"},{"issue":"350\u2013364","key":"3492_CR24","first-page":"e358","volume":"141","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Do DC, Ishmael FT, Squadrito ML, Tang HM, Tang HL, et al. Mannose receptor modulates macrophage polarization and allergic inflammation through miR-511-3p. J Allergy Clin Immunol. 2018;141(350\u2013364):e358.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR25","doi-asserted-by":"publisher","first-page":"e027808","DOI":"10.1136\/bmjopen-2018-027808","volume":"9","author":"BI Nwaru","year":"2019","unstructured":"Nwaru BI, Ekerljung L, Radinger M, Bjerg A, Mincheva R, Malmhall C, et al. Cohort profile: the West Sweden Asthma Study (WSAS): a multidisciplinary population-based longitudinal study of asthma, allergy and respiratory conditions in adults. BMJ Open. 2019;9:e027808.","journal-title":"BMJ Open"},{"key":"3492_CR26","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3492_CR27","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","DOI":"10.7554\/eLife.05005"},{"key":"3492_CR28","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N. MiRwalk: an online resource for prediction of microRNA binding sites. PLoS ONE. 2018;13:e0206239.","journal-title":"PLoS ONE"},{"key":"3492_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaci.2016.03.050","volume":"139","author":"P Wawrzyniak","year":"2017","unstructured":"Wawrzyniak P, Wawrzyniak M, Wanke K, Sokolowska M, Bendelja K, Ruckert B, et al. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol. 2017;139:93\u2013103.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00018-010-0500-x","volume":"68","author":"R Shaykhiev","year":"2011","unstructured":"Shaykhiev R, Otaki F, Bonsu P, Dang DT, Teater M, Strulovici-Barel Y, et al. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell Mol Life Sci. 2011;68:877\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"3492_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"issue":"W1","key":"3492_CR32","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"key":"3492_CR33","doi-asserted-by":"publisher","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","volume":"7","author":"DF Choy","year":"2015","unstructured":"Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S, et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med. 2015;7:301ra129.","journal-title":"Sci Transl Med"},{"key":"3492_CR34","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/hmg\/ddx053","volume":"26","author":"N Farahi","year":"2017","unstructured":"Farahi N, Paige E, Balla J, Prudence E, Ferreira RC, Southwood M, et al. Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma. Hum Mol Genet. 2017;26:1584\u201396.","journal-title":"Hum Mol Genet"},{"key":"3492_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1165\/rcmb.2010-0027TR","volume":"44","author":"R Halwani","year":"2011","unstructured":"Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q. Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol. 2011;44:127\u201333.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3492_CR36","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.4049\/jimmunol.1301360","volume":"191","author":"LK Fogli","year":"2013","unstructured":"Fogli LK, Sundrud MS, Goel S, Bajwa S, Jensen K, Derudder E, et al. T cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia. J Immunol. 2013;191:3100\u201311.","journal-title":"J Immunol"},{"key":"3492_CR37","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1165\/rcmb.2017-0031OC","volume":"57","author":"J Zhao","year":"2017","unstructured":"Zhao J, Minami Y, Etling E, Coleman JM, Lauder SN, Tyrrell V, et al. Preferential generation of 15-HETE-PE induced by IL-13 regulates goblet cell differentiation in human airway epithelial cells. Am J Respir Cell Mol Biol. 2017;57:692\u2013701.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3492_CR38","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaci.2015.02.039","volume":"136","author":"MC Larose","year":"2015","unstructured":"Larose MC, Chakir J, Archambault AS, Joubert P, Provost V, Laviolette M, et al. Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: involvement in patients with severe eosinophilic asthma. J Allergy Clin Immunol. 2015;136:904\u201313.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR39","doi-asserted-by":"publisher","first-page":"e0196256","DOI":"10.1371\/journal.pone.0196256","volume":"13","author":"Y Ito","year":"2018","unstructured":"Ito Y, Al Mubarak R, Roberts N, Correll K, Janssen W, Finigan J, et al. IL-13 induces periostin and eotaxin expression in human primary alveolar epithelial cells: comparison with paired airway epithelial cells. PLoS ONE. 2018;13:e0196256.","journal-title":"PLoS ONE"},{"key":"3492_CR40","doi-asserted-by":"publisher","first-page":"15858","DOI":"10.1073\/pnas.0707413104","volume":"104","author":"PG Woodruff","year":"2007","unstructured":"Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A. 2007;104:15858\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3492_CR41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jaci.2016.11.038","volume":"140","author":"PE Silkoff","year":"2017","unstructured":"Silkoff PE, Laviolette M, Singh D, FitzGerald JM, Kelsen S, Backer V, et al. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients. J Allergy Clin Immunol. 2017;140:710\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR42","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/thx.2003.014894","volume":"59","author":"C Lane","year":"2004","unstructured":"Lane C, Knight D, Burgess S, Franklin P, Horak F, Legg J, et al. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax. 2004;59:757\u201360.","journal-title":"Thorax"},{"issue":"670\u2013678","key":"3492_CR43","first-page":"e612","volume":"133","author":"A Poole","year":"2014","unstructured":"Poole A, Urbanek C, Eng C, Schageman J, Jacobson S, O\u2019Connor BP, et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol. 2014;133(670\u2013678):e612.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR44","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1056\/NEJMoa0708801","volume":"358","author":"C Ober","year":"2008","unstructured":"Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med. 2008;358:1682\u201391.","journal-title":"N Engl J Med"},{"issue":"2466\u20132468","key":"3492_CR45","first-page":"e2463","volume":"7","author":"P Ilmarinen","year":"2019","unstructured":"Ilmarinen P, Tuomisto LE, Niemela O, Hamalainen M, Moilanen E, Kankaanranta H. YKL-40 and adult-onset asthma: Elevated levels in clusters with poorest outcome. J Allergy Clin Immunol Pract. 2019;7(2466\u20132468):e2463.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3492_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ejhg.2010.191","volume":"19","author":"MA Ferreira","year":"2011","unstructured":"Ferreira MA, McRae AF, Medland SE, Nyholt DR, Gordon SD, Wright MJ, et al. Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia. Eur J Hum Genet. 2011;19:458\u201364.","journal-title":"Eur J Hum Genet"},{"key":"3492_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/path.1748","volume":"206","author":"AR Kranenburg","year":"2005","unstructured":"Kranenburg AR, Willems-Widyastuti A, Mooi WJ, Saxena PR, Sterk PJ, de Boer WI, et al. Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1. J Pathol. 2005;206:28\u201338.","journal-title":"J Pathol"},{"key":"3492_CR48","doi-asserted-by":"crossref","unstructured":"Calven J, Ax E, Radinger M. The Airway epithelium-a central player in asthma pathogenesis. Int J Mol Sci. 2020;21(23):8907.","DOI":"10.3390\/ijms21238907"},{"key":"3492_CR49","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.bbamem.2008.08.027","volume":"1788","author":"CT Capaldo","year":"2009","unstructured":"Capaldo CT, Nusrat A. Cytokine regulation of tight junctions. Biochim Biophys Acta. 2009;1788:864\u201371.","journal-title":"Biochim Biophys Acta"},{"issue":"951\u2013963","key":"3492_CR50","first-page":"e958","volume":"141","author":"B Steelant","year":"2018","unstructured":"Steelant B, Seys SF, Van Gerven L, Van Woensel M, Farre R, Wawrzyniak P, et al. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. J Allergy Clin Immunol. 2018;141(951\u2013963):e958.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR51","doi-asserted-by":"publisher","first-page":"3360310","DOI":"10.1155\/2023\/3360310","volume":"2023","author":"L Sun","year":"2023","unstructured":"Sun L, Wang L, Moore BB, Zhang S, Xiao P, Decker AM, et al. IL-17: balancing protective immunity and pathogenesis. J Immunol Res. 2023;2023:3360310.","journal-title":"J Immunol Res"},{"key":"3492_CR52","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","volume":"43","author":"JS Lee","year":"2015","unstructured":"Lee JS, Tato CM, Joyce-Shaikh B, Gulen MF, Cayatte C, Chen Y, et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity. 2015;43:727\u201338.","journal-title":"Immunity"},{"key":"3492_CR53","first-page":"726","volume":"62","author":"H Wu","year":"2024","unstructured":"Wu H, Li Y, Li X, Huang W, Huang Z, Lai X, et al. Il-17a disrupts the nasal mucosal epithelial barrier in patients with chronic rhinosinusitis by activating the ERK\/STAT3 pathway. Rhinology. 2024;62:726\u201338.","journal-title":"Rhinology"},{"key":"3492_CR54","doi-asserted-by":"publisher","first-page":"9798206","DOI":"10.1155\/2016\/9798206","volume":"2016","author":"M Ramezanpour","year":"2016","unstructured":"Ramezanpour M, Moraitis S, Smith JL, Wormald PJ, Vreugde S. Th17 cytokines disrupt the airway mucosal barrier in chronic rhinosinusitis. Mediators Inflamm. 2016;2016:9798206.","journal-title":"Mediators Inflamm"},{"key":"3492_CR55","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2009.02.024","volume":"123","author":"W Al-Ramli","year":"2009","unstructured":"Al-Ramli W, Prefontaine D, Chouiali F, Martin JG, Olivenstein R, Lemiere C, et al. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol. 2009;123:1185\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"3492_CR56","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.4049\/jimmunol.181.6.4089","volume":"181","author":"L McKinley","year":"2008","unstructured":"McKinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, Logar A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181:4089\u201397.","journal-title":"J Immunol"},{"key":"3492_CR57","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11882-011-0210-y","volume":"11","author":"YH Wang","year":"2011","unstructured":"Wang YH, Wills-Karp M. The potential role of interleukin-17 in severe asthma. Curr Allergy Asthma Rep. 2011;11:388\u201394.","journal-title":"Curr Allergy Asthma Rep"},{"key":"3492_CR58","doi-asserted-by":"publisher","first-page":"e71278","DOI":"10.1371\/journal.pone.0071278","volume":"8","author":"MS Leino","year":"2013","unstructured":"Leino MS, Loxham M, Blume C, Swindle EJ, Jayasekera NP, Dennison PW, et al. Barrier disrupting effects of alternaria alternata extract on bronchial epithelium from asthmatic donors. PLoS ONE. 2013;8:e71278.","journal-title":"PLoS ONE"},{"key":"3492_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1183\/09031936.00075612","volume":"42","author":"C Blume","year":"2013","unstructured":"Blume C, Swindle EJ, Dennison P, Jayasekera NP, Dudley S, Monk P, et al. Barrier responses of human bronchial epithelial cells to grass pollen exposure. Eur Respir J. 2013;42:87\u201397.","journal-title":"Eur Respir J"},{"key":"3492_CR60","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/01902148.2018.1533051","volume":"44","author":"H Zhang","year":"2018","unstructured":"Zhang H, Sun Y, Rong W, Fan L, Cai Y, Qu Q, et al. Mir-221 participates in the airway epithelial cells injury in asthma via targeting SIRT1. Exp Lung Res. 2018;44:272\u20139.","journal-title":"Exp Lung Res"},{"key":"3492_CR61","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.12659\/MSM.912412","volume":"25","author":"H Huang","year":"2019","unstructured":"Huang H, Lu H, Liang L, Zhi Y, Huo B, Wu L, et al. Microrna-744 inhibits proliferation of bronchial epithelial cells by regulating Smad3 pathway via targeting transforming growth factor-beta1 (TGF-beta1) in severe asthma. Med Sci Monit. 2019;25:2159\u201368.","journal-title":"Med Sci Monit"},{"key":"3492_CR62","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593\u2013601.","journal-title":"Nat Cell Biol"},{"key":"3492_CR63","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejphar.2015.04.031","volume":"761","author":"R Miyata","year":"2015","unstructured":"Miyata R, Kakuki T, Nomura K, Ohkuni T, Ogasawara N, Takano K, et al. Poly(I:C) induced microRNA-146a regulates epithelial barrier and secretion of proinflammatory cytokines in human nasal epithelial cells. Eur J Pharmacol. 2015;761:375\u201382.","journal-title":"Eur J Pharmacol"},{"key":"3492_CR64","doi-asserted-by":"crossref","unstructured":"Gil-Martinez M, Lorente-Sorolla C, Rodrigo-Munoz JM, Lendinez MA, Nunez-Moreno G, de la Fuente L, et al. Analysis of differentially expressed MicroRNAs in serum and lung tissues from individuals with severe asthma treated with oral glucocorticoids. Int J Mol Sci. 2023;24(2):1611.","DOI":"10.3390\/ijms24021611"},{"key":"3492_CR65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000525112","volume":"15","author":"M Liu","year":"2022","unstructured":"Liu M, Ren T, Lin Z, Hua M. Upregulated miR-146a expression in peripheral blood relates to Th17 and Treg imbalance in elder rheumatoid arthritis patients. Lifestyle Genom. 2022;15:98\u2013106.","journal-title":"Lifestyle Genom"},{"key":"3492_CR66","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1002\/ctm2.427","volume":"11","author":"A Laanesoo","year":"2021","unstructured":"Laanesoo A, Urgard E, Periyasamy K, Laan M, Bochkov YA, Aab A, et al. Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation. Clin Transl Med. 2021;11:e427.","journal-title":"Clin Transl Med"},{"key":"3492_CR67","doi-asserted-by":"publisher","first-page":"e0205434","DOI":"10.1371\/journal.pone.0205434","volume":"13","author":"KA Lambert","year":"2018","unstructured":"Lambert KA, Roff AN, Panganiban RP, Douglas S, Ishmael FT. Microrna-146a is induced by inflammatory stimuli in airway epithelial cells and augments the anti-inflammatory effects of glucocorticoids. PLoS ONE. 2018;13:e0205434.","journal-title":"PLoS ONE"},{"key":"3492_CR68","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/all.13619","volume":"74","author":"HT Tan","year":"2019","unstructured":"Tan HT, Hagner S, Ruchti F, Radzikowska U, Tan G, Altunbulakli C, et al. Tight junction, mucin, and inflammasome-related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice. Allergy. 2019;74:294\u2013307.","journal-title":"Allergy"},{"key":"3492_CR69","doi-asserted-by":"publisher","first-page":"e0163967","DOI":"10.1371\/journal.pone.0163967","volume":"11","author":"G Faura Tellez","year":"2016","unstructured":"Faura Tellez G, Willemse BW, Brouwer U, Nijboer-Brinksma S, Vandepoele K, Noordhoek JA, et al. Protocadherin-1 Localization and Cell-Adhesion Function in Airway Epithelial Cells in Asthma. PLoS ONE. 2016;11:e0163967.","journal-title":"PLoS ONE"},{"key":"3492_CR70","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1538\/expanim.21-0160","volume":"71","author":"S Meng","year":"2022","unstructured":"Meng S, Kang K, Fei D, Yang S, Pan S, Yu K, et al. Microrna-363-3p\/sphingosine-1-phosphate receptor 1 axis inhibits sepsis-induced acute lung injury via the inactivation of nuclear factor kappa-B ligand signaling. Exp Anim. 2022;71:305\u201315.","journal-title":"Exp Anim"},{"key":"3492_CR71","first-page":"697","volume":"12","author":"WZ Li","year":"2020","unstructured":"Li WZ, Zou Y, Song ZY, Wei ZW, Chen G, Cai QL, et al. Long non-coding RNA SNHG5 affects the invasion and apoptosis of renal cell carcinoma by regulating the miR-363-3p-Twist1 interaction. Am J Transl Res. 2020;12:697\u2013707.","journal-title":"Am J Transl Res"},{"key":"3492_CR72","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.7150\/jca.83897","volume":"14","author":"W Yang","year":"2023","unstructured":"Yang W, Yang X, Zhang Y, Li Y, Lv W. MiR-363 restrain the proliferation, migration and invasion of colorectal carcinoma cell by targeting E2F3. J Cancer. 2023;14:1362\u201370.","journal-title":"J Cancer"},{"key":"3492_CR73","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10863-021-09892-6","volume":"53","author":"Q Geng","year":"2021","unstructured":"Geng Q, Li Z, Li X, Wu Y, Chen N. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells. J Bioenerg Biomembr. 2021;53:321\u201332.","journal-title":"J Bioenerg Biomembr"},{"key":"3492_CR74","doi-asserted-by":"publisher","first-page":"10418","DOI":"10.1111\/jcmm.16970","volume":"25","author":"B Fan","year":"2021","unstructured":"Fan B, Su B, Song G, Liu X, Yan Z, Wang S, et al. MiR-363-3p induces EMT via the Wnt\/\u03b2-catenin pathway in glioma cells by targeting CELF2. J Cell Mol Med. 2021;25:10418\u201329.","journal-title":"J Cell Mol Med"},{"key":"3492_CR75","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/imm.12775","volume":"152","author":"M Kastle","year":"2017","unstructured":"Kastle M, Bartel S, Geillinger-Kastle K, Irmler M, Beckers J, Ryffel B, et al. MicroRNA cluster 106a\u2013363 is involved in T helper 17 cell differentiation. Immunology. 2017;152:402\u201313.","journal-title":"Immunology"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03492-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:05:01Z","timestamp":1769598301000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-025-03492-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3492"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03492-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Gothenburg Regional Ethical Committee (no.228\u201314), and written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"E.A., J.W., S.W., Z.J., and H.O. are employees of and hold stock\/stock options in AstraZeneca, which supported the study. C.L., H.I., J.C., C.M., and M.R. declare that they have no relevant conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}